Rebecca Clegg's practice focuses on complex intellectual property litigation and counseling, particularly in the fields of medical devices, pharmaceuticals, biotechnology, and semiconductors. Rebecca regularly litigates medical device and Hatch-Waxman Paragraph IV patent infringement suits. She also has experience representing clients in commercial litigation cases.

James (“Jimmy”) Attridge is an antitrust partner trusted to guide clients through cartel investigations, antitrust litigation, and complex merger reviews. With deep government experience across multiple administrations – including as chief of staff for the U.S. Department of Justice (DOJ) Antitrust Division and a federal prosecutor – Jimmy has helped clients successfully navigate some of the most challenging government investigations and litigation.

Experienced Hatch-Waxman Patent Litigator

As a first-chair trial attorney for major brand and generic drug companies in over 80 Hatch-Waxman Act cases, Aziz Burgy brings a wealth of experience to pharmaceutical patent litigation. Aziz has been honored among the top 3% of ANDA litigators in Patexia intelligence reports and is consistently recognized by various publications, including IAM Patent 1000, LMG Life Sciences, and Benchmark Litigation. Aziz also advises clients on FDA matters and with product selection to help clients target products for acquisition or development.

Eric Krause tries patent and trade secret cases, with experience spanning technologies from semiconductor fabrication and design to IoT and cloud computing. Drawing on his experience as a former electrical and computer engineer in the fields of BIOS, systems management, and network architecture at AMD – establishing itself as the initial supplier of 64-bit x86 CPUs – Eric crafts compelling defenses at trial based on the technology at issue. As a registered patent attorney, he frequently navigates the interplay between IPR  and litigation proceedings. His record for obtaining defense victories in key patent venues such as the Eastern and Western Districts of Texas, Delaware, the International Trade Commission (ITC), and the Patent Trial and Appeal Board (PTAB) has earned him recognition by IAM Patent 1000.

Matt Murphy leverages his prior experience as a research scientist to represent pharmaceutical, life sciences, and other companies in complex patent and trade secret litigation.

Matt Becker is the Chair of the Intellectual Property practice and has over 25 years of experience trying and litigating a diverse range of patent infringement and trade secret cases. He has tried numerous high-stakes cases to both courts and juries.

Rebecca Clegg's practice focuses on complex intellectual property litigation and counseling, particularly in the fields of medical devices, pharmaceuticals, biotechnology, and semiconductors. Rebecca regularly litigates medical device and Hatch-Waxman Paragraph IV patent infringement suits. She also has experience representing clients in commercial litigation cases.

James (“Jimmy”) Attridge is an antitrust partner trusted to guide clients through cartel investigations, antitrust litigation, and complex merger reviews. With deep government experience across multiple administrations – including as chief of staff for the U.S. Department of Justice (DOJ) Antitrust Division and a federal prosecutor – Jimmy has helped clients successfully navigate some of the most challenging government investigations and litigation.